AdvisorShares Pure US Cannabis ETF (MSOS)
After hours:
| Previous Close | 9.25 |
| Open | 9.02 |
| Bid | 8.83 x 1100 |
| Ask | 8.75 x 1200 |
| Day's Range | 8.73 - 9.26 |
| 52 Week Range | 4.78 - 10.95 |
| Volume | |
| Avg. Volume | 8,664,166 |
| Net Assets | 1.09B |
| NAV | 9.19 |
| PE Ratio (TTM) | N/A |
| Yield | 0.00% |
| YTD Daily Total Return | 31.95% |
| Beta (5Y Monthly) | 1.57 |
| Expense Ratio (net) | 0.83% |
| Inception Date | 2020-09-01 |
- Zacks
Cannabis ETFs: What's Behind the Latest Surge
While marijuana ETFs have seen a recent surge, investors should be aware of the potential risks
- Yahoo Finance Video
Cannabis regulation: Where reform could come from in 2024
On the backdrop of cannabis company Tilray (TLRY) — which is traded on the Nasdaq (^IXIC) but operates primarily in Canada — reporting record revenues in its fiscal second quarter of 2024, what are the prospects of marijuana regulation looking like in the 2024 presidential election? AdvisorShares Pure US Cannabis ETF Portfolio Manager Dan Ahrens — whose firm manages two cannabis ETFs (MSOS, YOLO) — comments on the hopes for cannabis reform being on 2024 ballots after administrative promises made in the past. "A lot of people expected reform when Biden first got elected and Democrats got control of the House and, sort of, the Senate," Ahrens says to Yahoo Finance. "This year we feel strongly that we're finally going to get federal reform by bypassing all those politicians and having the government agencies doing it." Click here to watch the full interview on the Yahoo Finance YouTube page or you can watch this full episode of Yahoo Finance Live here. Editor's note: This article was written by Luke Carberry Mogan.
ZacksCannabis ETFs Spike on Marijuana Classification Review
Marijuana stocks spiked following the report that the US Drug Enforcement Administration (DEA) is reviewing the potential reclassification of cannabis from Schedule I to Schedule III.
